CATECHOLAMINES EFFECTS ON CARDIOMYOCYTE MITOCHONDRIAL AND OXIDATIVE PHOSPHORYLATION ENZYMES

Authors

  • Mamatisakova Gulchexra Alimjanovna Andijan State Medical Institute

Keywords:

Сatecholamines, adrenaline, enzymes, beta adrenoreceptors, biogenic amines

Abstract

This review outlines the pharmacological possibilities of catecholamine signaling for the management of socially important disorders like hypertension, Parkinson's disease, and depression. Dopamine, norepinephrine, and epinephrine, the catecholamines, are released as hormones and as neurotransmitters in the nervous system. Prolactostatin, a hormone that is biochemically dopamine, is constantly released by hypothalamic neurons in both sexes. Norepinephrine activates the alpha and beta adrenoreceptors of target cells as the principal mediator released from the postganglionic endings of sympathetic neurons. Norepinephrine is released in little quantities as a hormone in the adrenal medulla, where it serves as a precursor to epinephrine production. Both norepinephrine and epinephrine trigger stress reactions through a generalized sympathetic "fight-or-flight" response, which raises cardiac output, blood pressure, and respiration.It is now crucial in cardiology to determine the mechanisms of adaptation to disturbances seen during hyperactive sympathetic nervous system activity in order to create effective treatments for cardiovascular disease.

References

Barrett, K., Brooks, H., Boitano, S. and Barman, S. 2010, Ganong’s review of Medical Physiology, 23rd Ed., The Mc Graw Hill Companies Inc., New York, 726.

Webster, R. A. 2001, Neurotransmitters, Drugs and Brain Function, John Wiley and Sons Ltd, Chichester, 520.

Smith, C. U. M. 2002, Elements of Molecular Neurobiology, 3rd Ed, John Wiley and Sons Ltd, Chichester, 630.

Murthy, L. I. 1975, Life Sciences, 17(12), 1777-1783.

Zhou, J. 2004, Drugs Future, 29(12), 1235- 1244.

Vardy, E., Steiner-Mordoch, S. and Schuldiner S. 2005, J. Bacteriol., 187(21), 7518-7525.

Al-Damluji, S. and Rees, L. H. 1987, J. Clin. Pathol., 40(9), 1098-1107.

Betito, K., Diorio, J., Meaney, M. J. and Boksa, P. 1992, J. Neurochem., 58(5), 1853- 1862.

Ritter, J., Flower, R., Henderson, G. and Rang, H. P. 2003, Pharmacology, Churchill Livingstone Edinburgh, 797.

Zamah, A. M., Delahunty, M., Luttrell, L. M. and Lefkowitz, R. J. 2002, J. Biol. Chem., 277(34), 31249-31256.

Published

2025-04-23

How to Cite

Mamatisakova Gulchexra Alimjanovna. (2025). CATECHOLAMINES EFFECTS ON CARDIOMYOCYTE MITOCHONDRIAL AND OXIDATIVE PHOSPHORYLATION ENZYMES. Ethiopian International Journal of Multidisciplinary Research, 12(04), 373–375. Retrieved from https://eijmr.org/index.php/eijmr/article/view/2929